Search for Clinical Trial Results
Hand-Foot Syndrome - 26 Studies Found
Status | Study |
Completed |
Study Name: Caelyx in Ovarian Cancer: Prevention and Treatment of Infusion Reactions and Palmar-plantar Erythrodysesthesia (Study P04085)(COMPLETED) Condition: Ovarian Neoplasms Date: 2008-08-26 Interventions: Drug: Caelyx (Pegylated Lyposomal Doxorubicin) Pegylated Lyposomal Doxorubicin, 50 mg/m2 every 4 weeks f |
Completed |
Study Name: Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer Condition:
|
Completed |
Study Name: A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020) Condition:
Date: 2008-09-03 |
Recruiting |
Study Name: Study On Fatigue- And Hand-Foot Syndrome-Related Quality Of Life In Patients With Metastatic Renal Cell Carcinoma Receiving A Tyrosine Kinase Inhibitor as First-Line Treatment Condition: Metastatic Renal Cell Carcinoma Date: 2016-05-17 |
Completed |
Study Name: DOXIL for Consolidation Therapy in Ovarian Cancer. Condition: Ovarian Neoplasm Date: 2005-11-01 Interventions: Drug: liposomal doxorubicin Doxil at 50mg/m2 infused over one hour every 3 or 4 weeks for 3-6 cycles |
RECRUITING |
Study Name: Ice Plant Intensive Cream for the Prevention of Hand-Foot Syndrome in Breast Cancer: Pilot Randomized Controlled Trial Condition: Hand-Foot Syndrome Date: 2024-05-19 Interventions: This group receives a 30-minute nursing consultation on the standard treatment according to the guideline "Supportive Therapy" for hand-foot |